Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 103

1.

Design and optimization strategies for the development of new drugs that treat chronic kidney disease.

Ramos AM, Fernández-Fernández B, Pérez-Gómez MV, Carriazo Julio SM, Sanchez-Niño MD, Sanz A, Ruiz-Ortega M, Ortiz A.

Expert Opin Drug Discov. 2020 Jan;15(1):101-115. doi: 10.1080/17460441.2020.1690450. Epub 2019 Nov 18.

PMID:
31736379
2.

Loss of NLRP6 expression increases the severity of acute kidney injury.

Valiño-Rivas L, Cuarental L, Nuñez G, Sanz AB, Ortiz A, Sanchez-Niño MD.

Nephrol Dial Transplant. 2019 Aug 29. pii: gfz169. doi: 10.1093/ndt/gfz169. [Epub ahead of print]

PMID:
31504777
3.

Lyso-Gb3 modulates the gut microbiota and decreases butyrate production.

Aguilera-Correa JJ, Madrazo-Clemente P, Martínez-Cuesta MDC, Peláez C, Ortiz A, Dolores Sánchez-Niño M, Esteban J, Requena T.

Sci Rep. 2019 Aug 19;9(1):12010. doi: 10.1038/s41598-019-48426-4.

4.

Atherosclerosis in Chronic Kidney Disease: More, Less, or Just Different?

Valdivielso JM, Rodríguez-Puyol D, Pascual J, Barrios C, Bermúdez-López M, Sánchez-Niño MD, Pérez-Fernández M, Ortiz A.

Arterioscler Thromb Vasc Biol. 2019 Oct;39(10):1938-1966. doi: 10.1161/ATVBAHA.119.312705. Epub 2019 Aug 15.

PMID:
31412740
5.

Dietary Care for ADPKD Patients: Current Status and Future Directions.

Carriazo S, Perez-Gomez MV, Cordido A, García-González MA, Sanz AB, Ortiz A, Sanchez-Niño MD.

Nutrients. 2019 Jul 12;11(7). pii: E1576. doi: 10.3390/nu11071576. Review.

6.

Obesity and chronic kidney disease progression-the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1.

Barbieri D, Goicoechea M, Sánchez-Niño MD, Ortiz A, Verde E, Verdalles U, Pérez de José A, Delgado A, Hurtado E, Sánchez-Cámara L, Lopez-Lazareno N, García-Prieto A, Luño J.

Clin Kidney J. 2018 Oct 11;12(3):420-426. doi: 10.1093/ckj/sfy095. eCollection 2019 Jun.

7.

MAP3K kinases and kidney injury.

Cuarental L, Sucunza-Sáenz D, Valiño-Rivas L, Fernandez-Fernandez B, Sanz AB, Ortiz A, Vaquero JJ, Sanchez-Niño MD.

Nefrologia. 2019 Nov - Dec;39(6):568-580. doi: 10.1016/j.nefro.2019.03.004. Epub 2019 Jun 10. Review. English, Spanish.

8.

NIK as a Druggable Mediator of Tissue Injury.

Valiño-Rivas L, Vaquero JJ, Sucunza D, Gutierrez S, Sanz AB, Fresno M, Ortiz A, Sanchez-Niño MD.

Trends Mol Med. 2019 Apr;25(4):341-360. doi: 10.1016/j.molmed.2019.02.005. Epub 2019 Mar 26. Review.

PMID:
30926358
9.

Podocyturia: why it may have added value in rare diseases.

Sanchez-Niño MD, Perez-Gomez MV, Valiño-Rivas L, Torra R, Ortiz A.

Clin Kidney J. 2018 Oct 5;12(1):49-52. doi: 10.1093/ckj/sfy081. eCollection 2019 Feb.

10.

Sarcopenia in CKD: a roadmap from basic pathogenetic mechanisms to clinical trials.

Ortiz A, Sanchez-Niño MD.

Clin Kidney J. 2019 Feb;12(1):110-112. doi: 10.1093/ckj/sfz001. Epub 2019 Feb 5.

11.

Working towards novel albuminuria endpoints in chronic kidney disease.

Fernandez-Fernandez B, Sanchez-Niño MD, Ortiz A.

Lancet Diabetes Endocrinol. 2019 Feb;7(2):80-82. doi: 10.1016/S2213-8587(18)30352-8. Epub 2019 Jan 8. No abstract available.

PMID:
30635227
12.

MAGE genes in the kidney: identification of MAGED2 as upregulated during kidney injury and in stressed tubular cells.

Valiño-Rivas L, Cuarental L, Agustin M, Husi H, Cannata-Ortiz P, Sanz AB, Mischak H, Ortiz A, Sanchez-Niño MD.

Nephrol Dial Transplant. 2019 Sep 1;34(9):1498-1507. doi: 10.1093/ndt/gfy367.

PMID:
30541139
13.

The Spanish Society of Nephrology (SENEFRO) commentary to the Spain GBD 2016 report: Keeping chronic kidney disease out of sight of health authorities will only magnify the problem.

Ortiz A, Sanchez-Niño MD, Crespo-Barrio M, De-Sequera-Ortiz P, Fernández-Giráldez E, García-Maset R, Macía-Heras M, Pérez-Fontán M, Rodríguez-Portillo M, Salgueira-Lazo M, Sánchez-Álvarez E, Santamaría-Olmo R, Simal-Blanco F, Pino-Pino MD.

Nefrologia. 2019 Jan - Feb;39(1):29-34. doi: 10.1016/j.nefro.2018.09.002. Epub 2018 Nov 28. English, Spanish.

15.

Population and fertility by age and sex for 195 countries and territories, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017.

GBD 2017 Population and Fertility Collaborators.

Lancet. 2018 Nov 10;392(10159):1995-2051. doi: 10.1016/S0140-6736(18)32278-5. Epub 2018 Nov 8. Erratum in: Lancet. 2019 Jun 22;393(10190):e44.

18.

Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017.

GBD 2017 Mortality Collaborators.

Lancet. 2018 Nov 10;392(10159):1684-1735. doi: 10.1016/S0140-6736(18)31891-9. Epub 2018 Nov 8. Erratum in: Lancet. 2019 Jun 22;393(10190):e44.

20.

Advances in understanding the role of angiotensin-regulated proteins in kidney diseases.

Sanz AB, Ramos AM, Soler MJ, Sanchez-Niño MD, Fernandez-Fernandez B, Perez-Gomez MV, Ortega MR, Alvarez-Llamas G, Ortiz A.

Expert Rev Proteomics. 2019 Jan;16(1):77-92. doi: 10.1080/14789450.2018.1545577. Epub 2018 Nov 27.

PMID:
30412432

Supplemental Content

Loading ...
Support Center